$0.82
-0.05 (-6.17%)
Open$0.87
Previous Close$0.87
Day High$0.87
Day Low$0.80
52W High$2.56
52W Low$0.47
Volume—
Avg Volume1.07M
Market Cap9.51M
P/E Ratio—
EPS$-0.88
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+3,320.3% upside
Current
$0.82
$0.82
Target
$27.92
$27.92
$15.39
$27.92 avg
$30.56
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 55.56M | 68.14M | 3.60M |
| Net Income | -5,909,783 | -6,522,939 | 438.1K |
| Profit Margin | -10.6% | -10.1% | 12.2% |
| EBITDA | -3,001,480 | -3,496,941 | 810.0K |
| Free Cash Flow | — | — | 302.1K |
| Rev Growth | -18.5% | -18.5% | +16.0% |
| Debt/Equity | — | — | 0.63 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |